1. Home
  2. JD vs HLN Comparison

JD vs HLN Comparison

Compare JD & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JD.com Inc.

JD

JD.com Inc.

N/A

Current Price

$29.39

Market Cap

39.2B

ML Signal

N/A

Logo Haleon plc (Each representing two)

HLN

Haleon plc (Each representing two)

N/A

Current Price

$10.02

Market Cap

42.8B

ML Signal

N/A

Company Overview

Basic Information
Metric
JD
HLN
Founded
2006
2022
Country
China
United Kingdom
Employees
N/A
N/A
Industry
Other Specialty Stores
Package Goods/Cosmetics
Sector
Consumer Discretionary
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
39.2B
42.8B
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
JD
HLN
Price
$29.39
$10.02
Analyst Decision
Strong Buy
Buy
Analyst Count
11
1
Target Price
$39.27
N/A
AVG Volume (30 Days)
9.0M
10.2M
Earning Date
05-12-2026
02-26-2026
Dividend Yield
3.37%
1.94%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.17
$6.55
Revenue Next Year
$6.01
$4.42
P/E Ratio
$9.17
$49.05
Revenue Growth
N/A
N/A
52 Week Low
$24.51
$8.65
52 Week High
$36.86
$11.28

Technical Indicators

Market Signals
Indicator
JD
HLN
Relative Strength Index (RSI) 43.23 56.43
Support Level $28.38 $9.98
Resistance Level $30.44 $10.23
Average True Range (ATR) 0.68 0.14
MACD -0.44 -0.02
Stochastic Oscillator 21.44 78.90

Price Performance

Historical Comparison
JD
HLN

About JD JD.com Inc.

JD.com is the third-largest Chinese e-commerce platform by gross merchandise volume in 2025. It offers a wide selection of authentic products with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace, and omnichannel businesses.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: